Italy tightens opioid security after 80 fentanyl vials stolen from Rome hospital

The theft of 80 fentanyl vials from a Rome hospital triggered an emergency government response, but Italy’s addiction chief says the real gap has always been enforcement of existing rules.

The Incident

Around 80 vials of fentanyl went missing from a hospital in Rome in late June, with the theft discovered during a routine count. Fentanyl is a powerful synthetic opioid used to treat severe pain but can be lethal in very small doses when misused.

Italian media reported the haul was enough to produce roughly 20,000 street doses, worth an estimated €150,000–300,000 on the black market.

There were no signs the safe had been forced, and with keys to the hospital pharmacy accessible to several staff members, investigators are examining the possibility of an inside job.

Government Response

The theft triggered an unusually swift, high-level response from the Italian government. Days later, senior officials, including the interior and health ministers, met at the prime minister’s office to agree on next steps:

• A technical working group with scientific societies to review storage and traceability rules for opioid medicines
• Tighter police checks across the supply chain

The trend was reinforced by another recent case. Last week, investigators in Florence said four people were under investigation over an alleged scheme involving forged prescriptions and doctors’ stamps stolen from a hospital to obtain opioids, including fentanyl, from several pharmacies in Tuscany for resale.

Expert Analysis

In an interview with Euractiv, Simona Pichini, director of the National Centre on Addiction and Doping at Italy’s National Institute of Health (ISS), said the legal framework itself was never the gap.

“Italy already has a very rigorous regulatory framework for managing medicines containing narcotic substances, including opioids,” she said, pointing to rules governing storage, registration and reporting obligations for hospitals.

“Often what needs checking is whether procedures are actually being followed, the quality of internal controls, staff training, and whether facilities can guarantee precise traceability across the whole hospital supply chain.”

She called the government’s push for stronger monitoring and audits “a step in the right direction,” provided it does not restrict legitimate access to pain treatment.

Pichini described the diversion of opioid medicines in Italy as real but limited to “very few episodes,” far from the scale of the US opioid epidemic. No deaths in Italy have been officially attributed solely to illicit fentanyl, she said.

Italy has had a national plan against fentanyl and synthetic opioid misuse since March 2024, while the ISS’s addiction centre serves as the operational arm of the national early-warning system tracking new substances and overdose clusters.

A Wider European Pattern

The Italian cases nevertheless come amid growing concern across Europe. Fentanyl-related deaths across 15 reporting EU member states nearly doubled between 2023 and 2024, from 129 to 208, according to the EU Drugs Agency’s 2026 European Drug Report, which notes that some fatalities may be linked to diverted fentanyl medicines.

The agency’s 2023 report also indicated that many fentanyl-related deaths in Europe could involve diverted medicines rather than illicitly manufactured fentanyl. Romania offers a concrete example: in 2023, police arrested a pharmacy employee for diverting fentanyl and other controlled opioids.

Hospital-level security remains a national competence, while the EU’s 2026–2030 drugs strategy does not address it, as the framework focuses primarily on trafficking rather than controls inside hospitals.

That leaves Rome’s technical working group with a task that appears simpler than it is: ensuring that existing rules are consistently enforced.